Yang Zhou

Yang Zhou

Auto-generated profile, based on publicly available information

Yang Zhou

Department of Orthopaedic Surgery, Henry Ford Hospital, Detroit, Michigan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
YJYongyu Jiang
Yongyu Jiang
CCChristine Chen
Christine Chen
XZXiaodong Zhang
Xiaodong Zhang
Chaoyang ChenChaoyang Chen
Chaoyang Chen
YZYang Zhou
Yang Zhou
SLStephen Lemos
Stephen Lemos

20 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SMSadreddin Mahmoodkalayeh
Sadreddin Mahmoodkalayeh
HJHossein Z. Jooya
Hossein Z. Jooya
AHAli Hariri
Ali Hariri
YZYang Zhou
Yang Zhou
QXQiuyun Xu
Qiuyun Xu
KAKamran Avanaki
Kamran Avanaki
We study the temperature dependence of the underlying mechanisms related to the signal strength and imaging depth in photoacoustic imaging. The presented theoretical and experimental results indicate that imaging depth can be improved by lowering the temperature of the intermediate medium that the laser passes through to reach the imaging target. We discuss the temperature dependency of optical and acoustic properties of the intermediate medium and their changes due to cooling. We demonstrate that the SNR improvement of the photoacoustic signal is mainly due to the reduction of Grüneisen parameter of the intermediate medium which leads to a lower level of background noise. These findings may open new possibilities toward the application of biomedical laser refrigeration.

1 April 2021 in JBJS Open Access
Verified
Journal Article
Open access
SFSreten Franovic
Sreten Franovic
APAlex Pietroski
Alex Pietroski
NKNoah Kuhlmann
Noah Kuhlmann
TBTalal Bazzi
Talal Bazzi
YZYang Zhou
Yang Zhou
SMStephanie Muh
Stephanie Muh
Background: The treatment of Rockwood Grade-III acromioclavicular (AC) joint separation has been widely disputed since the introduction of the classification system. The present literature does not reach consensus on whether operative or nonoperative management is more advantageous, nor does it effectively distinguish between operative measures. We hypothesized that nonoperative treatment of Rockwood Grade-III AC joint separation would be more cost-effective when compared with surgical options. Methods: We created a decision-tree model outlining the treatment of Rockwood Grade-III separations using nonoperative management or hook-plate, suture-button, or allograft fixation. After nonoperative intervention, the possible outcomes predicted by the model were uneventful healing, delayed operative management, a second round of sling use and physical therapy, or no reduction and no action; and after operative intervention, the possible outcomes were uneventful healing, loss of reduction and revision, and depending on the implant, loss of reduction and no action, or removal of the implant. A systematic review was conducted, and probabilities of each model state were averaged. A cost-effectiveness analysis was conducted both through rollback analysis yielding net monetary benefit and through incremental cost-effectiveness ratios (ICERs). Thresholds of $50,000/quality-adjusted life-year (QALY) and $100,000/QALY were used for ICER analysis. Furthermore, a sensitivity analysis was utilized to determine whether differential probabilities could impact the model. Results: Forty-five papers were selected from a potential 768 papers identified through our literature review. Nonoperative treatment was used as our reference case and showed dominance over all 3 of the operative measures at both the $50,000 and $100,000 ICER thresholds. Nonoperative treatment also showed the greatest net monetary benefit. Nonoperative management yielded the lowest total cost ($6,060) and greatest utility (0.95 QALY). Sensitivity analysis showed that allograft fixation became the favored technique at a willingness-to-pay threshold of $50,000 if the rate of failure of nonoperative treatment rose to 14.6%. Similarly, at the $100,000 threshold, allograft became dominant if the probability of failure of nonoperative treatment rose to 22.8%. Conclusions: The cost-effectiveness of nonoperative treatment is fueled by its notably lower costs and overall high rates of success in Grade-III separations. It is important to note that, in our analysis, the societal cost (measured in lost productivity) of nonoperative treatment neared that of surgical treatment, but the cost from the health-care system perspective was minimal. Physicians should bear in mind the sensitivity of these conclusions and should consider cost-effectiveness analyses in their decision-making guidelines. Level of Evidence: Economic and Decision Analysis Level IV. See Instructions for Authors for a complete description of levels of evidence.

25 June 2020
Verified
Journal Article
Open access
PDF file
YZYang Zhou
Yang Zhou
Chaoyang ChenChaoyang Chen
Chaoyang Chen
JNJuan Ni
Juan Ni
GNGuoxin Ni
Guoxin Ni
MLMin Li
Min Li
SLStephen Lemos
Stephen Lemos

1 February 2019 in MEDICAL DEVICES & SENSORS
Verified
Journal Article
Closed access
PDF file
XZXinuo Zhang
Xinuo Zhang
Chaoyang ChenChaoyang Chen
Chaoyang Chen
GNGuoxin Ni
Guoxin Ni
Yong HaiYong Hai
Yong Hai
BCBiao Chen
Biao Chen
MCMark Ming‐Cheng Cheng
Mark Ming‐Cheng Cheng